Chemoresistance profile of circulating tumor cells: Toward a clinical benefit?
Corresponding Author
Paola Gazzaniga
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Fax: 39-6-4454820.
Paola Gazzaniga and Angela Gradilone contributed equally to this work.
Department of Experimental Medicine, Viale Regina Elena, 324, 00161, Rome, ItalySearch for more papers by this authorAngela Gradilone
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Paola Gazzaniga and Angela Gradilone contributed equally to this work.
Search for more papers by this authorGiuseppe Naso
Division of Medical Oncology, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorEnrico Cortesi
Division of Medical Oncology, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorWalter Gianni
Division of Geriatry, I.N.R.C.A., IRCss, Rome, Italy
Search for more papers by this authorLuigi Frati
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorAnna Maria Aglianò
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorCorresponding Author
Paola Gazzaniga
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Fax: 39-6-4454820.
Paola Gazzaniga and Angela Gradilone contributed equally to this work.
Department of Experimental Medicine, Viale Regina Elena, 324, 00161, Rome, ItalySearch for more papers by this authorAngela Gradilone
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Paola Gazzaniga and Angela Gradilone contributed equally to this work.
Search for more papers by this authorGiuseppe Naso
Division of Medical Oncology, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorEnrico Cortesi
Division of Medical Oncology, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorWalter Gianni
Division of Geriatry, I.N.R.C.A., IRCss, Rome, Italy
Search for more papers by this authorLuigi Frati
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorAnna Maria Aglianò
Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy
Search for more papers by this authorFax: 39-6-4454820.
References
- 1 Jacob K,Sollier C,Jabado N. Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics. 2007; 4: 741–56.
- 2 Cristofanilli M,Budd GT,Ellis MJ,Stopeck A,Matera J,Miller MC,Reuben JM,Doyle GV,Allard WJ,Terstappen LW,Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351: 781–91.
- 3 Cristofanilli M,Broglio KR,Guarneri V,Jackson S,Fritsche HA,Islam R,Dawood S,Reuben JM,Kau SW,Lara JM,Krishnamurthy S,Ueno NT, et al. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 2007; 7: 471–9.
- 4 Budd GT,Cristofanilli M,Ellis MJ,Stopeck A,Borden E,Miller MC,Matera J,Repollet M,Doyle GV,Terstappen LW,Hayes DF. Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006; 12: 6403–9.
- 5 Cristofanilli M. The. “microscopic” revolution in breast carcinoma. Cancer 2005; 103: 877–80.
- 6 Bear HD. Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them? J Clin Oncol 2008; 26: 1195–1197.
- 7 Pachmann K,Camara O,Kavallaris A,Krauspe S,Malarski N,Gajda M,Kroll T,Jörke C,Hammer U,Altendorf-Hofmann A,Rabenstein C,Pachmann U, et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 2008; 26: 1208–15.
- 8 Bidard FC,Vincent-Salomon A,Sigal-Zafrani B,Diéras V,Mathiot C,Mignot L,Thiery JP,Sastre-Garau X,Pierga JY. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. Ann Oncol 2008; 19: 496–500.
- 9 Gillet JP,Efferth T,Remacle J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta 2007; 1775: 237–62.
- 10 Nakano Y,Tanno S,Koizumi K,Nishikawa T,Nakamura K,Minoguchi M,Izawa T,Mizukami Y,Okumura T,Kohgo Y. Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells. Br J Cancer 2007; 96: 457–63.
Citing Literature
